These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6372596)

  • 1. Prospects and problems in the definition and standardization of immunofluorescence. I. Present levels of reproducibility and disease specificity of antinuclear antibody tests.
    Beutner EH; Krasny S; Kumar V; Taylor R; Chorzelski TP
    Ann N Y Acad Sci; 1983; 420():28-54. PubMed ID: 6372596
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
    Stojan B
    Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
    [No Abstract]   [Full Text] [Related]  

  • 5. Antinuclear antibodies in systemic lupus erythematosus. Detection with horseradish-peroxidase-conjugated antibody.
    Benson MD; Cohen AS
    Ann Intern Med; 1970 Dec; 73(6):943-9. PubMed ID: 4947942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue specificity of antinuclear antibodies in scleroderma.
    Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of human antinuclear antibodies on rodent omenta.
    Holub M
    Allerg Immunol (Leipz); 1982; 28(2):118-21. PubMed ID: 6182782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 13. Substrate specificity of antinuclear antibodies in scleroderma.
    Blaszczyk M; Beutner EH; Rogozinski T; Rzesa G; Jarzabek-Chorzelska M; Jablonska S; Chorzelski TP
    J Invest Dermatol; 1977 Apr; 68(4):191-3. PubMed ID: 66298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.
    Ritchie RF
    Arthritis Rheum; 1968 Feb; 11(1):37-43. PubMed ID: 4867854
    [No Abstract]   [Full Text] [Related]  

  • 15. [Staining pattern of antinuclear antibody].
    Miyawaki S; Kurata N; Nishimura T; Ofuji T
    Arerugi; 1970 Apr; 19(4):282-93. PubMed ID: 4915379
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatic disease sera reactive with capillaries in the mouse kidney.
    Tan EM; Pearson CM
    Arthritis Rheum; 1972; 15(1):23-8. PubMed ID: 4551052
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of anti-DNA antibodies by electroimmunodiffusion. Comparison of the results with the study of antinuclear factors by immunofluorescence].
    Delpech A; Delpech B; Laumonier R
    Sem Hop; 1975 Mar; 51(14):945-9. PubMed ID: 175459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on antinuclear factors (ANF)--incidence and titer of ANE in patients with a variety of diseases and serial observations of titer in patients with SLE and scleroderma].
    Nagasawa T; Shibata S; Nakao K
    Nihon Naika Gakkai Zasshi; 1969 May; 58(5):371-8. PubMed ID: 4897897
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunofluorescence examination of blood, clinically unchanged skin, and kidneys in systemic lupus erythematosus].
    Stefanović Z; Stefanović M; Arnerić S; Mijailović B
    Zb Vojnomed Akad; 1975; ():18-21. PubMed ID: 801693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.